• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1800036 重组特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2018-04-24 上海联合赛尔生物工程有限公司 Shanghai United Cell Biotechnology Co Ltd Certificate Issued 2018-10-08 view
CXSL2000138 重组人特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2020-06-20 北京博康健基因科技有限公司 Beijing Genetech Pharmaceutical Co Ltd In Review 2020-06-19 view
CXHL2400319 特立帕肽注射液 teriparatide Injection Chemical Drugs(2.2) New Drug Application 2024-03-29 Yunnan Xianshi Pharmaceutical Co Ltd view
JYSB1500257 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2015-10-12 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2017-06-02 view
JYSB2200082 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2022-05-10 view
JXSS0900009 特立帕肽注射液 teriparatide Injection Biological Products Import Drug Application 2009-08-20 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2011-03-16 view
JTH2400172 特立帕肽注射液 teriparatide Injection Chemical Drugs Disposable Import Drug Application 2024-10-11 view
JYSZ1900023 特立帕肽注射液 teriparatide Injection Biological Products License Renew 2019-05-27 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2019-11-04 view
JXSL2101143 特立帕肽注射液 teriparatide Injection Biological Products(3.3) Import Drug Application 2021-12-02 view
JYSB2000245 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2020-06-19 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-06-22 view
CXSS2200073 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-08-16 Wuxi Hebang Bio-Tech Co Ltd view
CXSL2400506 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2024-08-01 Shanghai Duomirui Biotechnology Co Ltd view
JYSB1800293 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2018-12-17 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2019-02-28 view
CXSS2100011 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2021-01-19 信立泰(苏州)药业有限公司 Suzhou Genemen Biotech Co Ltd In Review 2021-01-19 view
CXHS2400015 特立帕肽注射液 teriparatide Injection Chemical Drugs(2.2) New Drug Application 2024-02-23 Hybio Pharmaceutical Co Ltd view
CXSL1500015 特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2015-06-15 上海联合赛尔生物工程有限公司 Shanghai United Cell Biotechnology Co Ltd Certificate Issued 2016-09-03 view
CXSS2200062 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-06-29 Beijing Genetech Pharmaceutical Co Ltd view
JYSB2400162 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2024-07-18 view
JYSB1800292 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2018-12-07 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2018-12-13 view
JYSB2000385 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2020-08-21 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-09-02 view